This article is not specifically about veterinary medicine though drug development and diseases on the human side still has implications on the veterinary side. We are several years behind in regard to some of the targeted therapies. The article though also talks about how as Big Pharma looks at more specific targeted therapies that won’t sell to large numbers of people, will the costs and regulation make them balk at providing this need.

Tags: Veterinary Medicine